Paul has brought a wealth of knowledge across pharmaceutical formulation development, analytical chemistry and manufacturing science. He has a positive, problem solving and professional manner that, combined with his industry knowledge, has provided Innoture with valuable support during internal and client facing drug development activities. His collaborative and friendly approach considers how Innoture is organised and our aims for the company, whilst also being keen to get his hands dirty with the technical team or preparing well-presented documents. In addition to his CMC expertise, he has provided efficient and effective guidance of Innoture’s intellectual property activities, including IP identification, patent filings, IP strategy coordination with patent attorneys and FTO.
Ken Jones
26 May 2022
Client Feedback...
Paul has brought a wealth of knowledge across pharmaceutical formulation development, analytical chemistry and manufacturing science. He has a positive, problem solving and professional manner that, combined with his industry knowledge, has provided Innoture with valuable support during internal and client facing drug development activities. His collaborative and friendly approach considers how Innoture is organised and our aims for the company, whilst also being keen to get his hands dirty with the technical team or preparing well-presented documents. In addition to his CMC expertise, he has provided efficient and effective guidance of Innoture’s intellectual property activities, including IP identification, patent filings, IP strategy coordination with patent attorneys and FTO.
Ken Jones
CEO
Innoture Ltd